Research advances on the pathogenesis and clinical interventions of post-stroke depression

Gao L, Song J, Zhao M, Wang R, Chen Y, Li M, An H, Zhou Z, Tan W, Huang Z (2026)


Publication Type: Journal article, Review article

Publication year: 2026

Journal

Book Volume: 17

Article Number: 1789695

DOI: 10.3389/fneur.2026.1789695

Abstract

Background – Post-stroke depression (PSD) is a common neuropsychiatric complication affecting 30–50% of stroke survivors, impairing rehabilitation, quality of life, and prognosis. Main body – This narrative review synthesizes recent evidence on PSD pathogenesis (neurotransmitter dysregulation, neuroinflammation, impaired neuroplasticity; psychosocial factors such as stress and social support deficits; gene–environment interactions including 5-HTT and BDNF polymorphisms), clinical interventions (pharmacotherapy with SSRIs/SNRIs, psychotherapy including CBT, neuromodulation via rTMS/tDCS/ECT, novel agents such as ketamine, and multidisciplinary models), and prevention (risk stratification, early screening with PHQ-9/HAMD, personalized biological/psychosocial strategies, and digital monitoring). Conclusion – Despite gaps in long-term data and validated biomarkers, multidisciplinary integrated care and precision medicine approaches offer promising avenues to optimize screening, early intervention, prevention, and long-term outcomes for stroke survivors.

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Gao, L., Song, J., Zhao, M., Wang, R., Chen, Y., Li, M.,... Huang, Z. (2026). Research advances on the pathogenesis and clinical interventions of post-stroke depression. Frontiers in Neurology, 17. https://doi.org/10.3389/fneur.2026.1789695

MLA:

Gao, Leqi, et al. "Research advances on the pathogenesis and clinical interventions of post-stroke depression." Frontiers in Neurology 17 (2026).

BibTeX: Download